Antimycobacterial activity of a new rifamycin derivative, 3-(4-cinnamylpiperazinyl iminomethyl) rifamycin SV (T9).

The antimycobacterial activities of a new rifampin (RIF) derivative, 3-(4-cinnamylpiperazinyl iminomethyl) rifamycin SV (To), against 20 susceptible and multidrug-resistant strains of Mycobacterium tuberculosis and 20 Mycobacterium avium complex (MAC) strains were investigated. The radiometric MICs...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Reddy, V M, Nadadhur, G, Daneluzzi, D, Dimova, V, Gangadharam, P R
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162936/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8619589/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.10.2320
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!